We are hiring for two positions including aDIRECTOR FOR PROGRAM EVALUATION (Tracking Code: 22500561490517) and a FINANCE & OPERATIONS ADMINISTRATOR (Tracking Code: 23500136350224),
If you are interested in learning more about them, please gohere.
Reminder
TL1 Predoctoral & Postdoctoral Fellowships in Regenerative Medicine
Application Deadline: Apr. 14, 2023
We are delighted to announce that the BU CTSI will support several predoctoral and postdoctoral fellows as part the CTSI training program in Regenerative Medicine. Learn More
The BU CTSI Voucher Program
Applications are Accepted on a Rolling Basis.
This Program supports the short-term needs of investigators that are not otherwise covered by grants. Vouchers are intended to enable preliminary work, generate data for new or ongoing projects, and/or secure fee-based core services for consultation services. Learn More
Scholar Programs &Funding Opportunity
ADDF-HARRINGTON SCHOLAR PROGRAM
LOI Deadline: May 29, 2023. Average Award: Up to $600,000/2 years
This Scholar Program is dedicated to advancing academic discoveries into medicines for Alzheimer’s disease and related dementias. More Details Here
AACR-NOVOCURE Career Development Award for Cancer Research
LOI Deadline: May 30, 2023. Available Grant: $300,000/3 Years
This award supports early-career investigators who are conducting innovative research focused on Tumor Treating Fields (TTF).
Advance your Career and the Future of Alzheimer’s Disease Research!
Application Deadline: Jun. 1, 2023. Budget: $10,000 Research Stipend
The BU ADRC Research Education Component (REC) is an interactive, mentored training program focusing on providing the next generation of Alzheimer’s Disease and Alzheimer’s Disease Related Disorders (AD/ADRD) researchers with the essential tools and competencies they need to launch a successful career in basic, clinical, and translational science. More Details Here
News Highlights
Long-term Protection and High Efficacy
of Bivalent BA.1 Booster Confirmed in Older Adults
The study revealed that protection with monovalent vaccine doses against hospitalization was long-lasting and plateaued around six months after the last vaccination, with modest protection at 15 months or later.Learn More
Study Highlights the Potential Long-term Neurological Effects Post-COVID-19
The researchers observed a substantial accumulation of SARS-CoV-2 S protein in the niches of human skull marrow, meninges, SMC, and brain parenchyma in both mouse and human-origin samples. Learn More
COVID-19 OpenData Portal
NCATS created a new resource for scientists, the OpenData Portal, to openly and quickly share COVID-19-related drug repurposing data and experiments for all approved drugs.The resource includes information protocols for using the assays, drug targets, mechanisms of drug action and screening assay data.
This seminar will introduce the NIH Comparative Genomics Resource (CGR), an NIH-funded, multi-year NLM project to establish an ecosystem to facilitate reliable comparative genomics analyses for all eukaryotic organisms in collaboration with the genomics community.Learn More
The Funding Acknowledgement
The Funding Acknowledgementguides recipients of BU CTSI services, resources, or funding for projects or research through the grant citation process. All recipients are required to cite our grant number in associated presentations and journal publications.
